Glutamate receptor ionotropic, kainate type (KAR) (KAR)

The kainate receptor (KAR) is a subtype of ionotropic glutamate receptor that mediates fast excitatory synaptic transmission and modulates synaptic plasticity throughout the central nervous system (UniProt Consortium, 2023). These receptors are tetrameric assemblies composed of various combinations of five subunits, GRIK1 through GRIK5, which determine their specific biophysical properties and pharmacological profiles (NCBI Gene, 2024). Unlike other glutamate receptors, KARs function in both presynaptic and postsynaptic capacities, where they regulate the release of neurotransmitters such as GABA and glutamate, thereby fine-tuning neural circuit excitability (Lerma & Marques, 2013). Dysregulation of kainate receptor activity is strongly implicated in the pathophysiology of neurological and psychiatric disorders, most notably temporal lobe epilepsy, where overactivation contributes to neuronal hyperexcitability and excitotoxicity (Contractor et al., 2011). They are also associated with chronic pain, schizophrenia, and depression, making them significant targets for drug development (StatPearls, 2023). Pharmacological agents targeting KARs include selective antagonists like tezampanel and LY466195, which have been investigated for treating migraines and seizures, although achieving high selectivity over AMPA receptors remains a primary therapeutic challenge (PubChem, 2024).

Other names

Kainate receptoriGluRGRIKIonotropic glutamate receptor kainate type

Kainate receptors function as ligand-gated ion channels that open upon glutamate binding to allow the influx of sodium and calcium ions. Therapeutic strategies involve competitive antagonism at the glutamate binding site or non-competitive allosteric modulation to reduce pathological hyperexcitability.